Arrowhead anticipates SHASTA-3/4 topline in Q3 while planning an SHTG sNDA before end of 2026
Arrowhead Research Corporation · PHARMACEUTICAL PREPARATIONS · Now $75.20
+7.1% in 3d after detection
Post-detection moves
1h
—
1d
+6.9%
3d
+7.1%
7d
+0.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS